{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:49Z","timestamp":1790226109294,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genome sequencing (GS) has recently been considered as a first-tier diagnostic tool for individuals with intellectual disability (ID) and developmental delay (DD). In this study, we assess the diagnostic yield of GS for a large cohort of children with ID\/DD and describe variants contributing to genetic diagnoses in this cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of consecutive GS results for individuals under 18 years of age with a clinical indication of ID\/DD was conducted using data from a clinical diagnostic laboratory. The present analysis included 666 individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this cohort, 31.1% (207\/666) of children received positive GS results. There were 186 children who received a genetic diagnosis that was at least partially associated with their history of ID\/DD, leading to a phenotype-specific diagnostic yield of GS for ID\/DD of 27.9%. For individuals without known prior genetic testing, 35.3% (103\/292) had positive GS results. There were 259 variants that led to genetic diagnoses in this cohort. Of these, 7.7% (20\/259) were variants with limited to no coverage on exome sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GS identified at least one genetic diagnosis associated with ID\/DD in 27.9% of children with ID\/DD as a clinical indication. An additional 3.2% of children received positive GS results associated with other features of their clinical indication. Almost 8% of variants related to the genetic diagnoses in this cohort may not have been detected through other standalone genomic technologies. These findings further support the recommendation by medical and professional societies of GS as a first-tier diagnostic test for individuals with ID\/DD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1966246","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:36:25Z","timestamp":1790224585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic yield of genome sequencing for children with intellectual disability and developmental delay"],"prefix":"10.3389","volume":"17","author":[{"given":"Robert","family":"Rigobello","sequence":"first","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Driver","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Robak","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]},{"name":"Texas Children\u2019s Hospital","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl A.","family":"Scott","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]},{"name":"Texas Children\u2019s Hospital","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Vossaert","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chibuk","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyan","family":"Meng","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Xia","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Eng","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Giannikopoulos","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]},{"name":"Innovative Genomics Institute","place":["Berkeley, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Baylor Genetics","place":["Houston, TX, United States"]},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"997648","DOI":"10.3389\/fpsyg.2022.997648","article-title":"Prevalence of neurodevelopmental disorders among US children and adolescents in 2019 and 2020","volume":"13","author":"Yang","year":"2022","journal-title":"Front Psychol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/pch\/pxy093","article-title":"Evaluation of the child with global developmental delay and intellectual disability","volume":"23","author":"B\u00e9langer","year":"2018","journal-title":"Paediatr Child Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/cge.12732","article-title":"Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test","volume":"89","author":"Thevenon","year":"2016","journal-title":"Clin Genet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s11689-022-09439-9","article-title":"The diagnostic journey of genetically defined neurodevelopmental disorders","volume":"14","author":"Simon","year":"2022","journal-title":"J Neurodev Disord"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/gim.2015.200","article-title":"Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability","volume":"18","author":"Monroe","year":"2016","journal-title":"Genet Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa1714458","article-title":"Effect of genetic diagnosis on patients with previously undiagnosed disease","volume":"379","author":"Splinter","year":"2018","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"105016","DOI":"10.1016\/j.ejmg.2025.105016","article-title":"Diagnostic delays in rare genetic disorders with neuropsychiatric manifestations: a systematic review","volume":"75","author":"Siegel","year":"2025","journal-title":"Eur J Med Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1542\/peds.2014-1839","article-title":"Comprehensive evaluation of the child with intellectual disability or global developmental delays","volume":"134","author":"Moeschler","year":"2014","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13643-025-02896-y","article-title":"Genetic testing for diagnosing neurodevelopmental disorders and epilepsy: a systematic review and meta-analysis","volume":"14","author":"Chang","year":"2025","journal-title":"Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/epi.16755","article-title":"Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: a systematic review and meta-analysis","volume":"62","author":"Stefanski","year":"2021","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1133789","DOI":"10.3389\/fped.2023.1133789","article-title":"The diagnostic yield of CGH and WES in neurodevelopmental disorders","volume":"11","author":"Alotibi","year":"2023","journal-title":"Front Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Manickam","year":"2021","journal-title":"Genet Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e2025072219","DOI":"10.1542\/peds.2025-072219","article-title":"Genetic evaluation of the child with intellectual disability or global developmental delay: clinical report","volume":"156","author":"Rodan","year":"2025","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/dmcn.14722","article-title":"Diagnostic yield and treatment impact of whole-genome sequencing in paediatric neurological disorders","volume":"63","author":"Lee","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ajhg.2023.07.007","article-title":"Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders","volume":"110","author":"Sanchis-Juan","year":"2023","journal-title":"Am J Hum Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41431-022-01185-9","article-title":"The performance of genome sequencing as a first-tier test for neurodevelopmental disorders","volume":"31","author":"van der Sanden","year":"2023","journal-title":"Eur J Hum Genet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/humu.24347","article-title":"Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay\/intellectual disability: a prospective study","volume":"43","author":"Sun","year":"2022","journal-title":"Hum Mutat"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.gim.2022.07.022","article-title":"Genome sequencing is a sensitive first-line test to diagnose individuals with intellectual disability","volume":"24","author":"Lindstrand","year":"2022","journal-title":"Genet Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e2415084","DOI":"10.1001\/jamanetworkopen.2024.15084","article-title":"Genetic testing for global developmental delay in early childhood","volume":"7","author":"Zhang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-023-00353-0","article-title":"Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population","volume":"8","author":"Slavotinek","year":"2023","journal-title":"NPJ Genom Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"105030","DOI":"10.1016\/j.ejmg.2025.105030","article-title":"Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders","volume":"76","author":"Neuens","year":"2025","journal-title":"Eur J Med Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/s41436-019-0554-6","article-title":"Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders","volume":"21","author":"Srivastava","year":"2019","journal-title":"Genet Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ajhg.2021.05.008","article-title":"Project baby bear: rapid precision care incorporating rWGS in 5 California children\u2019s hospitals demonstrates improved clinical outcomes and reduced costs of care","volume":"108","author":"Dimmock","year":"2021","journal-title":"Am J Hum Genet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/children10010106","article-title":"Breaking barriers to rapid whole genome sequencing in pediatrics: Michigan\u2019s project baby deer","volume":"10","author":"Bupp","year":"2023","journal-title":"Children"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jmoldx.2023.12.003","article-title":"Detection of constitutional structural variants by optical genome mapping: a multisite study of postnatal samples","volume":"26","author":"Broeckel","year":"2024","journal-title":"J Mol Diagn"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41431-018-0114-6","article-title":"Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing","volume":"26","author":"Costain","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cca.2021.09.015","article-title":"Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis","volume":"523","author":"Liu","year":"2021","journal-title":"Clin Chim Acta"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13073-022-01069-z","article-title":"Reanalysis of exome negative patients with rare disease: a pragmatic workflow for diagnostic applications","volume":"14","author":"Schobers","year":"2022","journal-title":"Genome Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1966246\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:36:28Z","timestamp":1790224588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1966246\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":28,"alternative-id":["10.3389\/fneur.2026.1966246"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1966246","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1966246"}}